Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries.
Eveliqure is a game-changer amongst vaccine companies, championing novel technologies to make the world safe from diarrhoea. Eveliqure is passionate about improving the quality of life for both the poor and the privileged by providing innovative medical solutions that fight diarrhoeal diseases.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Karl-Farkas-Gasse 22, Vienna,vienna 1030,austria
- of****@****ure.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- eveliqure.com
- Keywords
- THT Biomaterials GmbH.
- HQ
- Vienna, Vienna
Eveliqure Biotechnologies Questions
Eveliqure Biotechnologies's website is eveliqure.com
Eveliqure Biotechnologies's LinkedIn profile is https://at.linkedin.com/company/eveliqure-biotechnologies
Eveliqure Biotechnologies has
6 employees.
View email and phone details for 6
employees at Eveliqure Biotechnologies.
Eveliqure Biotechnologies's industry is
Biotechnology Research
Eveliqure Biotechnologies's top competitors are
Algonist Biotechnologies,
Ygion Biomedical,
Apeiron Biologics Ag,
Calyxha Biotechnologies,
Hookipa Pharma Inc.,
Tht Biomaterials Gmbh,
Valneva,
Evercyte Gmbh,
Biolution Gmbh,
Affiris Ag.
Eveliqure Biotechnologies's support email address is office@eveliqure.com
Eveliqure Biotechnologies's categories are Biotechnology Research
Eveliqure Biotechnologies's founding year is 2012
